Future risk of bradyarrhythmias in patients with hypertrophic cardiomyopathy and implantable cardioverter defibrillator indication

Back

ESC Premium Access

Future risk of bradyarrhythmias in patients with hypertrophic cardiomyopathy and implantable cardioverter defibrillator indication

Session: Poster Session 1 - Arrhythmia in cardiomyopathy

Topic: Prognosis and Risk Stratification

Speaker: Doctor K. Nakasuka (San Francisco, US)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Kosuke Nakasuka

University of California at San Francisco, San Francisco (United States of America)

0 follower

9 more presentations in this session

Dilated cardiomyopathy - a group that does not benefit from ICD?

Speaker: Doctor P. Silverio Antonio (Lisbon, PT)

Access

Abstract

Slides

Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy - data from the German device Registry

Speaker: Professor G. Frommeyer (Munster, DE)

Access

Abstract

Incidence of appropriate implantable cardioverter defibrillator therapy and sudden cardiac death in cardiac sarcoidosis - a systematic review and meta-analysis

Speaker: Mr K. Franke (Adelaide, AU)

Access

Abstract

Slides

Assessment of clinical risk factors for all-cause mortality among hypertrophic cardiomyopathy patients with ICDs.

Speaker: Mr S. Mielczarek (Warsaw, PL)

Access

Abstract

Slides

Predicting arrhythmic risk in dilated cardiomyopathy: a systematic review & meta-analysis of clinical parameters

Speaker: Doctor A. Sammani (Utrecht, NL)

Access

Abstract

Slides

Access the full session

Poster Session 1 - Arrhythmia in cardiomyopathy

Speakers: Doctor K. Nakasuka, Doctor P. Silverio Antonio, Professor G. Frommeyer, Mr K. Franke, Mr S. Mielczarek...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources